{
  "metadata": {
    "id": "U4AOS2-16-EnzymeInhibitors",
    "curriculum": "VCEAU",
    "subject": "chemistry",
    "dotPoint": "Competitive enzyme inhibitors and the lock-and-key mechanism",
    "colorTheme": {
      "primary": "#a855f7",
      "secondary": "#7c3aed"
    }
  },
  "tabs": [
    {
      "id": "lock-and-key",
      "label": "Lock and Key",
      "icon": "key",
      "order": 1
    },
    {
      "id": "competitive-inhibition",
      "label": "Competitive Inhibition",
      "icon": "ban",
      "order": 2
    },
    {
      "id": "drug-applications",
      "label": "Drug Applications",
      "icon": "pills",
      "order": 3
    }
  ],
  "concepts": {
    "lock-and-key": {
      "name": "Lock-and-Key Model",
      "formula": null,
      "correct": "The lock-and-key model proposes that substrate fits precisely into the enzyme's active site like a key in a lock",
      "wrong": {
        "enzyme changes shape completely": {
          "error": "Describing induced fit, not lock-and-key",
          "fix": "Lock-and-key assumes rigid, pre-formed complementary shapes",
          "action": "Lock-and-key: rigid; induced fit: flexible"
        },
        "any substrate can fit any enzyme": {
          "error": "Missing specificity principle",
          "fix": "Only substrates with correct shape fit the active site",
          "action": "Shape complementarity provides enzyme specificity"
        },
        "the lock is the substrate": {
          "error": "Reversing the analogy",
          "fix": "Enzyme is the lock (fixed); substrate is the key (fits into it)",
          "action": "Enzyme active site = lock; substrate = key"
        }
      },
      "persistent": {
        "gap": "Not understanding lock-and-key as shape complementarity",
        "action": "Active site shape precisely matches substrate shape"
      }
    },
    "enzyme-substrate-complex": {
      "name": "Enzyme-Substrate Complex",
      "formula": "E + S ⇌ ES → E + P",
      "correct": "Substrate binds to active site forming enzyme-substrate complex, then products are released",
      "wrong": {
        "enzyme is permanently changed": {
          "error": "Missing enzyme regeneration",
          "fix": "Enzyme is released unchanged and can catalyse more reactions",
          "action": "E + S → ES → E + P; enzyme recycled"
        },
        "binding is irreversible": {
          "error": "Missing equilibrium nature",
          "fix": "ES formation is reversible; substrate can dissociate without reacting",
          "action": "Equilibrium between E + S and ES"
        },
        "products stay bound": {
          "error": "Products must leave for turnover",
          "fix": "Products have different shape and leave the active site",
          "action": "Product release allows next substrate to bind"
        }
      },
      "persistent": {
        "gap": "Not understanding the catalytic cycle",
        "action": "Enzyme binds substrate, catalyses reaction, releases product, repeats"
      }
    },
    "competitive-inhibition": {
      "name": "Competitive Inhibition",
      "formula": null,
      "correct": "Competitive inhibitors bind to the active site, competing with substrate for the same binding location",
      "wrong": {
        "binds elsewhere on enzyme": {
          "error": "Describing non-competitive inhibition",
          "fix": "Competitive inhibitors bind AT the active site, blocking substrate",
          "action": "Competitive = active site; non-competitive = different site"
        },
        "permanently destroys enzyme": {
          "error": "Competitive inhibition is reversible",
          "fix": "Inhibitor binding is reversible; high substrate can overcome it",
          "action": "More substrate can outcompete the inhibitor"
        },
        "has completely different shape from substrate": {
          "error": "Missing structural similarity requirement",
          "fix": "Competitive inhibitors have similar shape to substrate to fit active site",
          "action": "Inhibitor mimics substrate shape"
        }
      },
      "persistent": {
        "gap": "Not understanding competitive inhibition mechanism",
        "action": "Similar-shaped inhibitor blocks substrate from active site"
      }
    },
    "inhibitor-structure": {
      "name": "Inhibitor Structure",
      "formula": null,
      "correct": "Competitive inhibitors structurally resemble the substrate to fit the active site",
      "wrong": {
        "any molecule can inhibit": {
          "error": "Missing structural requirement",
          "fix": "Only molecules with complementary shape to active site can bind",
          "action": "Inhibitor must fit the lock just like the substrate key"
        },
        "larger molecules are better inhibitors": {
          "error": "Size isn't the determining factor",
          "fix": "Shape complementarity matters most; size must match active site",
          "action": "Must fit active site, not just be large"
        },
        "inhibitors are always synthetic": {
          "error": "Missing natural inhibitors",
          "fix": "Many competitive inhibitors are natural products or derived from them",
          "action": "Both natural and synthetic competitive inhibitors exist"
        }
      },
      "persistent": {
        "gap": "Not connecting inhibitor structure to mechanism",
        "action": "Structural similarity to substrate allows active site binding"
      }
    },
    "reversibility": {
      "name": "Reversibility of Inhibition",
      "formula": null,
      "correct": "Competitive inhibition is reversible; increasing substrate concentration can overcome inhibition",
      "wrong": {
        "inhibition is always permanent": {
          "error": "Missing reversibility",
          "fix": "Competitive inhibitors bind reversibly via non-covalent interactions",
          "action": "Inhibitor can unbind; substrate can then bind"
        },
        "more inhibitor always wins": {
          "error": "Missing substrate competition",
          "fix": "High substrate concentration can outcompete inhibitor for active sites",
          "action": "It's a competition: more substrate = less inhibition"
        },
        "maximum velocity cannot be reached": {
          "error": "Incorrect effect on Vmax",
          "fix": "With enough substrate, Vmax can be reached despite inhibitor",
          "action": "Competitive inhibition increases Km but doesn't change Vmax"
        }
      },
      "persistent": {
        "gap": "Not understanding competitive inhibition reversibility",
        "action": "Substrate and inhibitor compete; excess substrate overcomes inhibition"
      }
    },
    "drug-design": {
      "name": "Drug Design",
      "formula": null,
      "correct": "Many drugs work as competitive enzyme inhibitors, blocking enzymes involved in disease",
      "wrong": {
        "all drugs are enzyme inhibitors": {
          "error": "Overgeneralising mechanism",
          "fix": "Many drugs work by other mechanisms (receptor binding, etc.)",
          "action": "Enzyme inhibition is one important drug mechanism among many"
        },
        "inhibiting any enzyme is therapeutic": {
          "error": "Missing target selectivity",
          "fix": "Drug must inhibit specific disease-related enzyme without affecting others",
          "action": "Selectivity is crucial to avoid side effects"
        },
        "drugs bind permanently": {
          "error": "Most competitive drugs bind reversibly",
          "fix": "Reversible binding allows dose adjustment and cessation",
          "action": "Reversible inhibitors allow controlled therapy"
        }
      },
      "persistent": {
        "gap": "Not connecting enzyme inhibition to drug action",
        "action": "Drugs can block disease-related enzymes by competitive inhibition"
      }
    },
    "examples": {
      "name": "Inhibitor Examples",
      "formula": null,
      "correct": "Statins inhibit cholesterol synthesis enzyme; many antibiotics inhibit bacterial enzymes",
      "wrong": {
        "only one class of drugs uses inhibition": {
          "error": "Missing diversity of inhibitor drugs",
          "fix": "Many drug classes use enzyme inhibition: statins, antibiotics, antivirals, etc.",
          "action": "Enzyme inhibition is widespread in pharmacology"
        },
        "inhibitors are toxic": {
          "error": "Confusing inhibition with toxicity",
          "fix": "Selective inhibition of disease-related enzymes is therapeutic, not toxic",
          "action": "Correct target = medicine; wrong target = poison"
        },
        "examples are only synthetic": {
          "error": "Missing natural inhibitors",
          "fix": "Penicillin (natural antibiotic) is a competitive enzyme inhibitor",
          "action": "Natural and synthetic enzyme inhibitors both used as drugs"
        }
      },
      "persistent": {
        "gap": "Not knowing examples of enzyme inhibitor drugs",
        "action": "Learn: statins (HMG-CoA reductase), antibiotics (transpeptidase)"
      }
    },
    "selectivity": {
      "name": "Enzyme Selectivity",
      "formula": null,
      "correct": "Effective drugs selectively inhibit target enzymes without affecting similar enzymes elsewhere",
      "wrong": {
        "selectivity doesn't matter": {
          "error": "Missing importance of selectivity",
          "fix": "Non-selective inhibitors cause side effects by affecting non-target enzymes",
          "action": "Selectivity = efficacy with minimal side effects"
        },
        "all enzymes are equally affected": {
          "error": "Missing enzyme diversity",
          "fix": "Active sites differ; inhibitor binds best to target enzyme",
          "action": "Design inhibitors to fit target but not similar enzymes"
        },
        "perfect selectivity is easy": {
          "error": "Underestimating challenge",
          "fix": "Achieving high selectivity is a major drug design challenge",
          "action": "Related enzymes may have similar active sites"
        }
      },
      "persistent": {
        "gap": "Not understanding selectivity importance in drug design",
        "action": "Good drug: high target inhibition, low off-target effects"
      }
    }
  },
  "content": {
    "round1": {
      "lock-and-key": {
        "sentences": [
          {
            "text": "The lock-and-key model compares the enzyme's {0} site to a lock and the {1} to a key.",
            "questions": [
              {
                "correct": "active",
                "distractors": ["binding", "allosteric", "catalytic"],
                "concept": "lock-and-key",
                "tooltip": "Active site is the 'lock'"
              },
              {
                "correct": "substrate",
                "distractors": ["product", "enzyme", "inhibitor"],
                "concept": "lock-and-key",
                "tooltip": "Substrate is the 'key'"
              }
            ]
          },
          {
            "text": "In this model, the substrate has a {0} shape that fits precisely into the {1} shape of the active site.",
            "questions": [
              {
                "correct": "complementary",
                "distractors": ["identical", "opposite", "random"],
                "concept": "lock-and-key",
                "tooltip": "Shapes are complementary, not identical"
              },
              {
                "correct": "fixed",
                "distractors": ["changing", "flexible", "variable"],
                "concept": "lock-and-key",
                "tooltip": "Lock-and-key assumes rigid active site"
              }
            ]
          },
          {
            "text": "When substrate binds to enzyme, an {0}-{1} complex forms. This then breaks down to release {2} and regenerate the enzyme.",
            "questions": [
              {
                "correct": "enzyme",
                "distractors": ["inhibitor", "product", "water"],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Enzyme part of the complex"
              },
              {
                "correct": "substrate",
                "distractors": ["product", "water", "ion"],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Substrate binds to form ES complex"
              },
              {
                "correct": "products",
                "distractors": ["substrates", "enzymes", "inhibitors"],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Products are released after reaction"
              }
            ]
          }
        ]
      },
      "competitive-inhibition": {
        "sentences": [
          {
            "text": "A competitive inhibitor has a similar {0} to the substrate and binds to the {1} site.",
            "questions": [
              {
                "correct": "shape",
                "distractors": ["colour", "mass", "charge only"],
                "concept": "inhibitor-structure",
                "tooltip": "Structural similarity is key"
              },
              {
                "correct": "active",
                "distractors": ["allosteric", "different", "random"],
                "concept": "competitive-inhibition",
                "tooltip": "Competitive inhibitors bind AT active site"
              }
            ]
          },
          {
            "text": "When the inhibitor occupies the active site, the {0} cannot bind, so the {1} is slowed.",
            "questions": [
              {
                "correct": "substrate",
                "distractors": ["product", "enzyme", "water"],
                "concept": "competitive-inhibition",
                "tooltip": "Inhibitor blocks substrate binding"
              },
              {
                "correct": "reaction",
                "distractors": ["colour change", "mass", "volume"],
                "concept": "competitive-inhibition",
                "tooltip": "Less substrate binding = slower reaction"
              }
            ]
          },
          {
            "text": "Competitive inhibition is {0} because increasing {1} concentration can overcome the inhibition.",
            "questions": [
              {
                "correct": "reversible",
                "distractors": ["irreversible", "permanent", "fixed"],
                "concept": "reversibility",
                "tooltip": "Inhibitor can be displaced"
              },
              {
                "correct": "substrate",
                "distractors": ["inhibitor", "enzyme", "product"],
                "concept": "reversibility",
                "tooltip": "More substrate outcompetes inhibitor"
              }
            ]
          }
        ]
      },
      "drug-applications": {
        "sentences": [
          {
            "text": "Many drugs work as {0} enzyme inhibitors, blocking enzymes involved in {1}.",
            "questions": [
              {
                "correct": "competitive",
                "distractors": ["random", "destructive", "enhancing"],
                "concept": "drug-design",
                "tooltip": "Drugs often competitively inhibit enzymes"
              },
              {
                "correct": "disease",
                "distractors": ["health", "growth", "nutrition"],
                "concept": "drug-design",
                "tooltip": "Target enzymes are disease-related"
              }
            ]
          },
          {
            "text": "Effective enzyme inhibitor drugs must be {0}, affecting the target enzyme without inhibiting {1} enzymes.",
            "questions": [
              {
                "correct": "selective",
                "distractors": ["random", "universal", "destructive"],
                "concept": "selectivity",
                "tooltip": "Selectivity minimises side effects"
              },
              {
                "correct": "other",
                "distractors": ["the same", "no", "all"],
                "concept": "selectivity",
                "tooltip": "Avoid off-target effects"
              }
            ]
          },
          {
            "text": "Statins are competitive inhibitors of HMG-CoA {0}, an enzyme involved in {1} synthesis.",
            "questions": [
              {
                "correct": "reductase",
                "distractors": ["synthase", "kinase", "phosphatase"],
                "concept": "examples",
                "tooltip": "HMG-CoA reductase is the target"
              },
              {
                "correct": "cholesterol",
                "distractors": ["protein", "DNA", "glucose"],
                "concept": "examples",
                "tooltip": "Statins lower cholesterol"
              }
            ]
          }
        ]
      }
    },
    "round2": {
      "lock-and-key": {
        "sentences": [
          {
            "text": "The lock-and-key model explains enzyme {0}: only substrates with the correct {1} can fit the active site. A different substrate is like a wrong {2} that doesn't fit the lock.",
            "questions": [
              {
                "correct": "specificity",
                "distractors": ["colour", "mass", "charge"],
                "concept": "lock-and-key",
                "tooltip": "Shape matching provides specificity"
              },
              {
                "correct": "shape",
                "distractors": ["colour", "mass", "charge"],
                "concept": "lock-and-key",
                "tooltip": "Shape complementarity is essential"
              },
              {
                "correct": "key",
                "distractors": ["lock", "door", "handle"],
                "concept": "lock-and-key",
                "tooltip": "Wrong key won't fit the lock"
              }
            ]
          },
          {
            "text": "The enzyme-substrate complex is held together by {0} interactions between the substrate and amino acids in the {1} site. These include hydrogen bonds, ionic interactions, and {2} forces.",
            "questions": [
              {
                "correct": "non-covalent",
                "distractors": ["covalent only", "metallic", "nuclear"],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Non-covalent = reversible binding"
              },
              {
                "correct": "active",
                "distractors": ["passive", "random", "external"],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Binding occurs at active site"
              },
              {
                "correct": "hydrophobic",
                "distractors": ["magnetic", "gravitational", "nuclear"],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Non-polar regions interact"
              }
            ]
          }
        ]
      },
      "competitive-inhibition": {
        "sentences": [
          {
            "text": "A competitive inhibitor resembles the {0} closely enough to fit the active site, but unlike the substrate, it doesn't undergo the {1} reaction. It just {2} the site.",
            "questions": [
              {
                "correct": "substrate",
                "distractors": ["product", "enzyme", "water"],
                "concept": "inhibitor-structure",
                "tooltip": "Inhibitor mimics substrate shape"
              },
              {
                "correct": "catalytic",
                "distractors": ["binding", "folding", "dissolving"],
                "concept": "competitive-inhibition",
                "tooltip": "Inhibitor is not converted to product"
              },
              {
                "correct": "blocks",
                "distractors": ["destroys", "expands", "creates"],
                "concept": "competitive-inhibition",
                "tooltip": "Inhibitor occupies the site"
              }
            ]
          },
          {
            "text": "With competitive inhibition, {0} substrate concentration can restore enzyme activity because substrate molecules can {1} inhibitor molecules for active site {2}.",
            "questions": [
              {
                "correct": "high",
                "distractors": ["low", "zero", "negative"],
                "concept": "reversibility",
                "tooltip": "Excess substrate overcomes inhibition"
              },
              {
                "correct": "outcompete",
                "distractors": ["join", "destroy", "enhance"],
                "concept": "reversibility",
                "tooltip": "Numbers game: more substrate = more binding"
              },
              {
                "correct": "binding",
                "distractors": ["colour", "mass", "charge"],
                "concept": "reversibility",
                "tooltip": "They compete for same binding site"
              }
            ]
          },
          {
            "text": "The effect of competitive inhibition on enzyme kinetics: the apparent {0} increases (harder to saturate enzyme), but maximum {1} remains unchanged (at high substrate, inhibition is overcome).",
            "questions": [
              {
                "correct": "Km",
                "distractors": ["Vmax", "pH", "temperature"],
                "concept": "reversibility",
                "tooltip": "Km increases with competitive inhibitor"
              },
              {
                "correct": "velocity",
                "distractors": ["mass", "colour", "charge"],
                "concept": "reversibility",
                "tooltip": "Vmax unchanged; just need more substrate"
              }
            ]
          }
        ]
      },
      "drug-applications": {
        "sentences": [
          {
            "text": "Penicillin is a competitive inhibitor of the bacterial enzyme {0}. This enzyme is essential for building bacterial cell {1}. Without it, bacteria cannot {2}.",
            "questions": [
              {
                "correct": "transpeptidase",
                "distractors": ["DNA polymerase", "ATP synthase", "ribosome"],
                "concept": "examples",
                "tooltip": "Transpeptidase builds cell wall"
              },
              {
                "correct": "walls",
                "distractors": ["membranes", "DNA", "ribosomes"],
                "concept": "examples",
                "tooltip": "Cell wall synthesis is blocked"
              },
              {
                "correct": "survive and reproduce",
                "distractors": ["photosynthesize", "digest", "think"],
                "concept": "examples",
                "tooltip": "Wall-less bacteria die"
              }
            ]
          },
          {
            "text": "Drug designers analyse the {0} of the target enzyme's active site. They then design molecules with complementary {1} that will bind tightly but not be processed as {2}.",
            "questions": [
              {
                "correct": "structure",
                "distractors": ["colour", "smell", "taste"],
                "concept": "drug-design",
                "tooltip": "Know the active site structure"
              },
              {
                "correct": "shape",
                "distractors": ["colour", "smell", "taste"],
                "concept": "drug-design",
                "tooltip": "Design shape to fit active site"
              },
              {
                "correct": "substrates",
                "distractors": ["enzymes", "products", "inhibitors"],
                "concept": "drug-design",
                "tooltip": "Inhibitor doesn't react"
              }
            ]
          },
          {
            "text": "Selectivity challenges: human and bacterial enzymes may have {0} active sites. An antibiotic must bind bacterial enzyme but not the {1} human equivalent.",
            "questions": [
              {
                "correct": "similar",
                "distractors": ["identical", "opposite", "unrelated"],
                "concept": "selectivity",
                "tooltip": "Evolved from common ancestors"
              },
              {
                "correct": "similar",
                "distractors": ["different", "larger", "smaller"],
                "concept": "selectivity",
                "tooltip": "Must discriminate between similar enzymes"
              }
            ]
          }
        ]
      }
    },
    "round3": {
      "lock-and-key": {
        "sentences": [
          {
            "text": "The lock-and-key model was proposed by Emil Fischer. While useful, it has been refined by the {0} fit model, which recognises that active sites can undergo {1} changes upon substrate binding. Both models emphasise {2} complementarity.",
            "questions": [
              {
                "correct": "induced",
                "distractors": ["forced", "random", "permanent"],
                "concept": "lock-and-key",
                "tooltip": "Induced fit allows flexibility"
              },
              {
                "correct": "conformational",
                "distractors": ["colour", "mass", "charge"],
                "concept": "lock-and-key",
                "tooltip": "Shape can adjust slightly"
              },
              {
                "correct": "shape",
                "distractors": ["colour", "mass", "charge"],
                "concept": "lock-and-key",
                "tooltip": "Shape matching remains central"
              }
            ]
          },
          {
            "text": "When the enzyme-substrate complex forms, the substrate is held in the optimal {0} for the reaction. Functional groups in the active site may participate in {1}. After reaction, products have {2} shape and leave the active site.",
            "questions": [
              {
                "correct": "orientation",
                "distractors": ["colour", "mass", "charge"],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Correct positioning is essential"
              },
              {
                "correct": "catalysis",
                "distractors": ["inhibition", "denaturation", "folding"],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Active site residues assist reaction"
              },
              {
                "correct": "different",
                "distractors": ["identical", "same", "complementary"],
                "concept": "enzyme-substrate-complex",
                "tooltip": "Products don't fit well, so they leave"
              }
            ]
          }
        ]
      },
      "competitive-inhibition": {
        "sentences": [
          {
            "text": "Comparing substrate and competitive inhibitor: both have {0} shapes that fit the active site. The substrate is converted to {1}; the inhibitor is {2}. This means inhibitor occupies the site without productive reaction.",
            "questions": [
              {
                "correct": "similar",
                "distractors": ["identical", "different", "opposite"],
                "concept": "inhibitor-structure",
                "tooltip": "Similar but not identical shapes"
              },
              {
                "correct": "products",
                "distractors": ["inhibitors", "enzymes", "substrates"],
                "concept": "competitive-inhibition",
                "tooltip": "Substrate undergoes catalysis"
              },
              {
                "correct": "not converted",
                "distractors": ["converted", "destroyed", "multiplied"],
                "concept": "competitive-inhibition",
                "tooltip": "Inhibitor just occupies site"
              }
            ]
          },
          {
            "text": "Methotrexate is a competitive inhibitor of dihydrofolate {0}, an enzyme essential for {1} synthesis. Cancer cells need rapid DNA synthesis, so inhibiting this enzyme slows {2} growth.",
            "questions": [
              {
                "correct": "reductase",
                "distractors": ["synthase", "kinase", "phosphatase"],
                "concept": "examples",
                "tooltip": "DHFR is the target enzyme"
              },
              {
                "correct": "DNA",
                "distractors": ["fat", "carbohydrate", "water"],
                "concept": "examples",
                "tooltip": "Folate needed for nucleotide synthesis"
              },
              {
                "correct": "tumour",
                "distractors": ["normal", "healthy", "nerve"],
                "concept": "examples",
                "tooltip": "Anticancer drug targets rapid division"
              }
            ]
          }
        ]
      },
      "drug-applications": {
        "sentences": [
          {
            "text": "The drug design process for competitive inhibitors: (1) identify disease-related {0}, (2) determine active site {1}, (3) design molecules that fit the site but aren't {2}, (4) test for {3} (binding target vs others).",
            "questions": [
              {
                "correct": "enzyme",
                "distractors": ["colour", "smell", "taste"],
                "concept": "drug-design",
                "tooltip": "Find the enzyme to target"
              },
              {
                "correct": "structure",
                "distractors": ["colour", "smell", "taste"],
                "concept": "drug-design",
                "tooltip": "Know the active site in detail"
              },
              {
                "correct": "substrates",
                "distractors": ["inhibitors", "drugs", "proteins"],
                "concept": "drug-design",
                "tooltip": "Don't want it to react"
              },
              {
                "correct": "selectivity",
                "distractors": ["colour", "smell", "taste"],
                "concept": "selectivity",
                "tooltip": "Must only affect target"
              }
            ]
          },
          {
            "text": "HIV protease inhibitors are competitive inhibitors that block viral {0} processing. They resemble the natural {1} sequence that the protease normally cleaves. By blocking this enzyme, new virus particles cannot {2}.",
            "questions": [
              {
                "correct": "protein",
                "distractors": ["fat", "carbohydrate", "water"],
                "concept": "examples",
                "tooltip": "HIV protease processes viral proteins"
              },
              {
                "correct": "peptide",
                "distractors": ["lipid", "sugar", "nucleotide"],
                "concept": "inhibitor-structure",
                "tooltip": "Inhibitors mimic peptide substrates"
              },
              {
                "correct": "mature",
                "distractors": ["infect", "reproduce", "survive"],
                "concept": "examples",
                "tooltip": "Immature virus particles are non-infectious"
              }
            ]
          }
        ]
      }
    }
  },
  "explanations": {
    "lock-and-key": "The lock-and-key model proposes rigid complementary shapes between enzyme active site (lock) and substrate (key).",
    "enzyme-substrate-complex": "Substrate binds to active site forming ES complex, then products are released and enzyme is recycled.",
    "competitive-inhibition": "Competitive inhibitors bind to active site, blocking substrate; similar shape to substrate required.",
    "inhibitor-structure": "Competitive inhibitors structurally resemble substrates to fit and block the active site.",
    "reversibility": "Competitive inhibition is reversible; high substrate concentration can outcompete inhibitor.",
    "drug-design": "Many drugs work as selective competitive enzyme inhibitors targeting disease-related enzymes.",
    "examples": "Statins (cholesterol), antibiotics (bacterial wall), antivirals (viral processing) use competitive inhibition.",
    "selectivity": "Effective drugs selectively inhibit target enzymes without affecting similar enzymes, minimising side effects."
  }
}
